Markey Cancer Center at Lexington Clinic

Medical oncology and infusion services at 1221 South Broadway in Lexington, and oncology, infusion and radiation therapy services at 793 Eastern Bypass, Suite G2 in Richmond, are now being provided collaboratively between the two organizations. Markey Cancer Center is the only National Cancer Institute (NCI)-designated cancer center in Kentucky and one of only 70 in the nation. As part of the collaboration, patients will benefit from enhanced specialty pharmacy services, supportive treatment services, clinical trials and more.

Lexington Clinic medical oncology and advanced practice providers will continue to provide services as part of the Markey Cancer Center at Lexington Clinic. Patients who already have been receiving care at one of the Lexington Clinic sites will continue to see their same physicians and providers.

“Just a few short months ago negotiations and discussions began between UK HealthCare and Lexington Clinic and due to the desire to combine our strengths to provide the best cancer care to Central Kentuckians, we are elated to have reached this milestone,” said Dr. Mark F. Newman, UK executive vice president for health affairs.

UK HealthCare is focused on bolstering its outpatient services in critical clinical areas such as cancer. The relationship with Lexington Clinic expands the number of patients who could participate in clinical trials, crucial to the development of new drugs and therapies at the Markey Cancer Center. It also creates opportunities to boost UK’s tripartite mission of excellence in research, education and clinical care within the Bluegrass.